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Good’s syndrome is extremely rare. This adult-onset condition is characterized by a thymoma with immunodeficiency, 
low B- and T-cell counts, and hypo-gammaglobulinemia. The initial clinical presentation is either a mass-lesion thymoma 
or  a  recurrent  infection.  Patients  with  Good’s  syndrome  are  very  susceptible  to  infections;  common  respiratory  and 
opportunistic  infections  can  be  life-threatening.  There  are  no  reports  of  granulomatous  lung  disease  in  patients  with 
Good’s syndrome, although it has been observed in patients with common variable immunodeficiency, of which Good’s 
syndrome  is  a  subset.  We  describe  a  53-year-old  male  thymoma  patient  who  presented  with  respiratory  symptoms 
caused  by  granulomatous  lung  disease  and  an  opportunistic  infection.  He  died  of  uncontrolled  fungal  infection  despite 
repeated intravenous immunoglobulin and supportive care. Clinicians should look for evidence of immunologic dysfunction 
in  thymoma  patients  presenting  with  severe  recurrent  infections,  especially  opportunistic  infections.
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INTRODUCTION
Good’s  syndrome,  a  combination  of  thymoma  and  adult- 
onset  immunodeficiency,  is  a  rare  cause  of  combined  B-  and 
T-cell immunodeficiency. It is classified as a primary immunode-
ficiency
1), and patients usually present with recurrent infections or 
a  mediastinal  mass
2).  The  precise  cause  and  pathogenesis  of 
this  disorder  are  unclear,  although  there  is  evidence  that  the 
primary  defect  is  associated  with  bone  marrow  defects,  including 
pre-B  cell  arrest  and  impaired  maturation  of  erythroid  and 
myeloid  precursors
3).
Patients with Good’s syndrome are susceptible to infections 
with  encapsulated  bacteria  and  opportunistic  viruses  and  fungi. 
We describe a patient with Good’s syndrome who developed a 
severe  infection  subsequent  to  a  thymectomy  to  remove  a 
thymoma.  Our  patient  had  granulomatous  lung  disease,  which 
became  infected  with  Pneumocystis  jirovecii.
CASE REPORT
A  53-year-old  man  presented  at  our  hospital  with  a  7-day 
history  of  exertional  dyspnea.  He  also  complained  of  a 
productive cough, which he had had for about 40 days. He had 
undergone  an  extended  thymectomy  to  remove  a  lymphoe-
p i t h e l i o i d  t y p e  o f  t h y m o m a  5  m o n t h s  p r e v i o u s l y  a n d  h a d  
received 45 Grays of adjuvant radiotherapy. Two months before 
admission,  he  was  diagnosed  with  sarcoidosis  based  on  the 
results of an imaging study (Figure 1) and a transbronchial lung 
biopsy  (Figure  2).  However,  his  medication  was  changed  to  an 
anti-tuberculosis  chemotherapeutic  regimen  10  days  before 
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Figure 1. Initial high-resolution computed tomography (HRCT) showed multiple small nodules with a fuzzy, patchy infiltration in both lung fields (A, 
B). HRCT 2 months after commencing steroid treatment revealed that the  number  of micronodules  had  decreased,  but  a  new  cavitary  lesion had
developed in the right upper lobe (C, D). HRCT conducted 10 days after commencing anti-tuberculosis treatment revealed the presence of a new
b i l a t e r a l  d i f f u s e  G G O  a n d  a  s l i g h t  i n c r e a s e  i n  t h e  s i z e  o f  t h e  c a v i t a r y  n o d u l e  i n  r i g h t  u p p e r  l o b e  ( E ,  F ) .
Figure  2.  A  transbronchial  lung-biopsy  section  of  the  right  lower  lobe 
obtained  during  the  first  evaluation  shows  a  noncaseating  granuloma 
c o m p o s e d  o f  m u l t i n u c l e a t e d  g i a n t  c e l l s  a n d  a  f e w  h i s t i o c y t e s  ( H &E 
stain,  ×200).
high-resolution  computed  tomography  (HRCT).
O n  a d m i s s i o n  t o  o u r  h o s p i t a l ,  h e  h a d  a  b l o o d  p r e s s u r e  o f  
90/60 mmHg, a body temperature of 39.3℃, a pulse rate of 152 
beats  per  minute,  and  a  respiration  rate  of  32  breaths  per 
minute. Physical examination revealed inspiratory crackles in both 
lower lung fields.  A chest roentgenogram showed haziness and 
disseminated  nodules  in  both  lung  fields  and  conglomerated 
cavities  in  the  right  upper  lobe.
Computerized tomography (CT) of the chest revealed multiple 
micronodular densities and multiple cavitary nodules in the right 
upper  lobe.  Comparison  with  CT  obtained  10  days  previously 
showed  that  his  condition  had  worsened.  In  addition,  new 
regions  of  ground  glass  opacity  (GGO)  were  detected  in  both 
lower  lobes  (Figure  1).
Laboratory analyses revealed a white blood cell count of 3500 
cells/mm
3 (79.6% segmental forms), a hemoglobin of 15.2 g/dL, 
a  platelet  cell  count  of  253,000  cells/mm
3,  an  erythrocyte 
sedimentation rate of 36 mm/h, and a C-reactive protein level of 
17.29  mg/dL.  His  hepatic  function  was  normal,  except  for  a 
mildly elevated aspartate aminotransferase (AST) level of 81 U/L. 
Renal function was normal and an HIV test was negative. Arterial 
blood  gas  analysis  (fraction  of  inspired  oxygen 0.44)  revealed  a 
pH  of  7.44,  a  PaCO2  of  34.0  mmHg,  a  PaO2  of  60.5  mmHg,  a 
bicarbonate  (HCO3)  level  of  22.8  mmol/L,  and  an  SaO2  of 
9 1 . 9 % .  T h e  p a t i e n t  w a s  a d mi t t e d  t o  t h e  i n t e n s i v e  c a r e  u n i t .
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basal  segment  of  the  right  lower  lobe  to  identify  the  causative 
organism.  The  cell  count  from  the  BAL  fluid  was  119/μL,  and 
the  cell  differential  showed  30%  macrophages,  60%  lympho-
cytes  (CD4/CD8=7/46),  and  10%  neutrophils.  Polymerase  chain 
reaction  (PCR)  and  direct  florescent  antibody  (DFA)  analyses  of 
the  lavage  fluid  were  positive  for  Pneumocystis  jirovecii.  Culture 
for  cytomegalovirus  (CMV)  was  negative.  Trimethoprim/sulfa-
methoxazole  and  methylprednisolone  were  administered  because 
o f  t h e  p r e s e n c e  o f  P.  jirovecii.
The  result  of  a  neutrophil  dihydrorhodamine  test,  which 
assesses  the  immune  function  of  polymorphonuclear  cells  from 
the  oxidase  peak,  was  normal.
The  patient’s  cell  counts  were  as  follows:  T  lymphocytes 
(CD3),  290/μL;  B lymphocytes  (CD19),  0/μL;  CD4,  148/μL, 
and  CD8,  132/μL.  His  immunoglobulin  levels  were  low:  IgG, 
507  mg/dL;  IgA,  31  mg/dL;  and  IgM  <3  mg/dL.
Although  we  performed  a  video-assisted  thoracoscopic 
biopsy, the biopsy specimens revealed only diffuse thickening of 
the  alveolar  wall  with  fibrosis  and  lymphocyte  infiltration.  The 
analysis of a smear of the specimen for acid-fast bacilli and the 
immunohistochemical  analysis  for  CMV,  herpes  simplex  virus 
(HSV), and adenovirus antigens were negative. Having diagnosed 
Good’s  syndrome,  we  continued  supportive  ventilatory  care  and 
antibiotic  treatment  for  acute  respiratory  distress  syndrome.
Since the hypogammaglobulinemia persisted despite antibiotic 
treatment,  the  patient  was  given  regular  intravenous  immuno-
globulin  (IVIG)  infusions.  However,  the  pneumonia  and  diarrhea 
did  not  improve  and  the  infection  worsened.  Culture  of  the 
pleural  fluid  and  material  from  the  catheter  tip  showed  the 
presence of Candida albicans. The patient died of septic shock 
and  multi-organ  failure  caused  by  uncontrolled  fungal  infection 
d u r i n g  t h e  t h i r d  m o n t h  a f t e r  a d mi s s i o n .
DISCUSSION
The  patient  had  hypogammaglobulinemia  and  had  previously 
undergone  a  thymectomy.  He  died  of  uncontrolled  fungal 
infection that originated from damaged skin and a central venous 
catheter.
Good’s syndrome (immunodeficiency with concomitant thymoma) is 
a  rare  cause  of  combined  B-  and  T-cell  immunodeficiency  in 
adults. In 1954, Good first reported a thymoma coexistent with 
hypogammaglobulinemia
2).
Patients  with  Good’s  s y n d r o m e  u s u a l l y  p r e s e n t  i n  t h e  4
th o r  
5
th  decade  of  life,  and  the  frequency  in  males  and  females  is 
similar.  The  immunodeficiency  may  precede  or  follow  the 
diagnosis  of  a  thymoma
2),  but  the  immunologic  abnormalities 
cannot  be  corrected  by  corticosteroid  treatment  or  thymec-
tomy
4).
The combination of common variable immunodeficiency (CVID) 
and thymoma is known as Good’s syndrome
2). As this condition 
satisfies the criteria for a combined immunodeficiency presenting 
in infancy with severe lethal infections
1), it may be regarded as a 
subset of CVID
5). Diffuse interstitial lung disorders (granulomatous 
lung  disease,  lymphocytic  interstitial  pneumonia,  follicular  bro-
nchiolitis,  and  bronchiolitis  obliterans  with  organizing  pneumonia) 
that are refractory to IVIG treatment occur in approximately 25% of 
p a t i e n t s  w i t h  C V I D .  A s  t h e s e  d i s o r d e r s  a r e  c o n s i s t e n t  w i t h  t h e  
diagnostic  criteria  for  Good’s  syndrome
6,  7),  there  is  considerable 
debate  regarding  the  nature  and  clinical  course  of  granulomatous 
lung  disease  in  patients  such  as  ours
8, 9).
Cases of non-necrotizing granulomatous lung disease that are 
resistant to corticosteroid therapy have been reported. Bates et 
al.
10)  proposed  that  granulomatous  lymphocytic  lung  disease 
s h o r t e n s  t h e  s u r v i v a l  o f  C V I D  p a t i e n t s .
The  cause  of  granulomatous  disease  in  CVID  patients  is 
unclear.  Some  believe  it  is  a  sarcoidosis  of  immunocom-
promised  patients,  whereas  others  contend  that  it  is  a  unique 
clinical  disorder
11).
Good’s  syndrome  is  classified  as  a  distinct  primary 
immunodeficiency
1). Although the cause and pathogenesis of this 
disorder are unknown, its main characteristics are hypogamma-
globulinemia;  a  low  B-cell  count  or  the  absence  of  B  cells; 
variable  defects  in  cell-mediated  immunity  such  as  CD4+  T-cell 
lymphopenia  and  a  reduced  T-cell  proliferative  response  to 
mitogens;  and  reduced  serum  levels  of  IgG,  IgA,  and  IgM
4).  A 
reduced  mature  B-cell  count  in  bone  marrow  has  also  been 
reported
12).
Since cell-mediated immunity is compromised, individuals with 
Good’s  syndrome  are  susceptible  to  bacterial  infections,  parti-
cularly infections with encapsulated organisms, and opportunistic 
viral  and fungal  infections.  Thymoma  occurs in  10%  of  patients 
with  adult-onset  hypogammaglobulinemia,  whereas  3～6%  of 
thymoma  patients  have  hypogammaglobulinemia
4).
Tarr  et  al.
2)  reported  that  sinopulmonary  infection  with 
Haemophilus influenza was the most common infectious disease 
among 51 patients with immunodeficiency and thymoma. Other 
infectious  diseases  present  in  their  patients  were  CMV, 
Pneumocystis  jirovecii,  infectious  diarrhea,  and  tuberculosis. 
Although  systemic  fungal  infections  are  not  characteristic  of 
Good’s syndrome, mucocutaneous candidiasis occurs in 24% of 
cases
4).  Autoimmune  diseases  such  as  myasthenia  gravis,  pure 
red-cell  aplasia,  pernicious  anemia,  diabetes  mellitus,  and 
idiopathic  thrombocytopenia  also  occur
1).  Although  our  patient 
did  not  have  an  autoimmune  disease,  he  had  a  history  of 
frequent  respiratory  infections  that  were  aggravated  after  the 
t h y m e c t o m y .  T h e  p a t i e n t  d i e d  o f  Candida  infection.
The  treatment  of  patients  with  Good’s  syndrome  includes 
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maintain  adequate  IgG  levels.  IVIG  improves  the  control  of 
infections, reduces the duration of hospitalization, decreases the 
quantity  of  antibiotics  used,  and  might  prevent  chronic  lung 
damage  and  bronchiectasis
2, 13, 14).
According to a follow-up report
2), 29 of 50 Good’s syndrome 
patients  died.  A  favorable  response  during  the  follow-up  period 
was observed for 23 of 30 patients, although the response was 
often transient. Nine of the 22 responders and six of the seven 
non-responders  died.  Hermaszewski  et  al.  reported  that  the  5- 
and  10-year  survival  rates  were  70  and  33%,  respectively
15).
In  summary,  we  report  a  rare  case  of  granulomatous  lung 
disease  similar  to  that  observed  in  CVID,  of  which  Good’s 
syndrome is a subset. Good’s syndrome should be suspected in 
patients  with  thymoma  or  CVID  who  develop  repeated 
respiratory  infections,  especially  opportunistic  infections.
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